Skip to main content
Erschienen in: Clinical and Experimental Medicine 1/2016

01.02.2016 | Original Article

Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case–control study

verfasst von: Alexandra S. Shadrina, Natalia A. Ermolenko, Uljana A. Boyarskikh, Tatiana V. Sinkina, Alexandr F. Lazarev, Valentina D. Petrova, Maxim L. Filipenko

Erschienen in: Clinical and Experimental Medicine | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Genetic variation in DNA repair genes can alter an individual’s capacity to repair damaged DNA and influence the risk of cancer. We tested seven polymorphisms in DNA repair genes XRCC1, ERCC2, XRCC3, XRCC2, EXOI and TP53 for a possible association with breast cancer risk in a sample of 672 case and 672 control Russian women. An association was observed for allele A of the polymorphism XRCC1 (R399Q) rs25487 (co-dominant model AA vs. GG: OR 1.76, P = 0.003; additive model OR 1.28, P = 0.005; dominant model: OR 1.29, P = 0.03; recessive model OR 1.63, P = 0.008). Allele T of the polymorphism ERCC2 (D312N) rs1799793 was also associated with breast cancer risk (co-dominant model TT vs. CC: OR 1.43, P = 0.04; additive model OR 1.21, P = 0.02; dominant model: OR 1.30, P = 0.02), but the association became insignificant after applying Bonferroni correction. No association with breast cancer was found for the remaining SNPs. In summary, our study provides evidence that polymorphisms in DNA repair genes may play a role in susceptibility to breast cancer in the population of ethnical Russians.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Davydov MI, Aksel EM. Cancer statistics in Russia and CIS in 2012. Moscow: Russian Cancer Research Center Publishing Group; 2014. Davydov MI, Aksel EM. Cancer statistics in Russia and CIS in 2012. Moscow: Russian Cancer Research Center Publishing Group; 2014.
7.
Zurück zum Zitat Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:1513–30. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:1513–30.
10.
Zurück zum Zitat Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557–61.PubMed Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557–61.PubMed
14.
Zurück zum Zitat Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis. 2004;25:757–63. doi:10.1093/carcin/bgh064.CrossRefPubMed Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis. 2004;25:757–63. doi:10.​1093/​carcin/​bgh064.CrossRefPubMed
16.
Zurück zum Zitat Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092–100.CrossRefPubMedPubMedCentral Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092–100.CrossRefPubMedPubMedCentral
19.
20.
Zurück zum Zitat Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC, Nakamura J. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res. 2006;66:2860–8. doi:10.1158/0008-5472.CrossRefPubMed Pachkowski BF, Winkel S, Kubota Y, Swenberg JA, Millikan RC, Nakamura J. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res. 2006;66:2860–8. doi:10.​1158/​0008-5472.CrossRefPubMed
21.
Zurück zum Zitat Jelonek K, Gdowicz-Klosok A, Pietrowska M, et al. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010;51:343–52. doi:10.1007/BF03208865.CrossRefPubMed Jelonek K, Gdowicz-Klosok A, Pietrowska M, et al. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010;51:343–52. doi:10.​1007/​BF03208865.CrossRefPubMed
23.
Zurück zum Zitat Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W. A population-based case–control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomark Prev. 2003;12:1462–7. Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W. A population-based case–control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomark Prev. 2003;12:1462–7.
25.
Zurück zum Zitat Hsu MS, Yu JC, Wang HW, et al. Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk. Ann Surg Oncol. 2010;17:760–71. doi:10.1245/s10434-009-0802-0.CrossRef Hsu MS, Yu JC, Wang HW, et al. Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk. Ann Surg Oncol. 2010;17:760–71. doi:10.​1245/​s10434-009-0802-0.CrossRef
26.
Zurück zum Zitat Kim SU, Park SK, Yoo KY, et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics. 2002;12:335–8.CrossRefPubMed Kim SU, Park SK, Yoo KY, et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics. 2002;12:335–8.CrossRefPubMed
27.
Zurück zum Zitat Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomark Prev. 2001;10:217–22. Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomark Prev. 2001;10:217–22.
29.
Zurück zum Zitat Kuschel B, Chenevix-Trench G, Spurdle AB, et al. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomark Prev. 2005;14:1828–31. doi:10.1158/1055-9965.EPI-04-0807.CrossRef Kuschel B, Chenevix-Trench G, Spurdle AB, et al. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomark Prev. 2005;14:1828–31. doi:10.​1158/​1055-9965.​EPI-04-0807.CrossRef
31.
Zurück zum Zitat Mechanic LE, Millikan RC, Player J, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case–control study. Carcinogenesis. 2006;27:1377–85. doi:10.1093/carcin/bgi330.CrossRefPubMed Mechanic LE, Millikan RC, Player J, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case–control study. Carcinogenesis. 2006;27:1377–85. doi:10.​1093/​carcin/​bgi330.CrossRefPubMed
33.
Zurück zum Zitat Song B, Zhu JY, Liu J, et al. Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin’s lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008;16:97–100.PubMed Song B, Zhu JY, Liu J, et al. Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin’s lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008;16:97–100.PubMed
34.
Zurück zum Zitat Jakubowska A, Gronwald J, Menkiszak J, et al. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat. 2010;119:201–11. doi:10.1007/s10549-009-0390-5.CrossRefPubMed Jakubowska A, Gronwald J, Menkiszak J, et al. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat. 2010;119:201–11. doi:10.​1007/​s10549-009-0390-5.CrossRefPubMed
35.
Zurück zum Zitat Forsti A, Angelini S, Festa F, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep. 2004;11:917–22.PubMed Forsti A, Angelini S, Festa F, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep. 2004;11:917–22.PubMed
38.
Zurück zum Zitat Millikan RC, Player JS, Decotret AR, Tse CK, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomark Prev. 2005;14:2326–34. doi:10.1158/1055-9965.EPI-05-0186.CrossRef Millikan RC, Player JS, Decotret AR, Tse CK, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomark Prev. 2005;14:2326–34. doi:10.​1158/​1055-9965.​EPI-05-0186.CrossRef
43.
44.
Zurück zum Zitat Murata M, Tagawa M, Kimura H, Kakisawa K, Shirasawa H, Fujisawa T. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients. Int J Oncol. 1998;12:577–81. doi:10.3892/ijo.12.3.577.PubMed Murata M, Tagawa M, Kimura H, Kakisawa K, Shirasawa H, Fujisawa T. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients. Int J Oncol. 1998;12:577–81. doi:10.​3892/​ijo.​12.​3.​577.PubMed
45.
Zurück zum Zitat Zdzienicka MZ, van der Schans GP, Natarajan AT, Thompson LH, Neuteboom I, Simons JW. A Chinese hamster ovary cell mutant (EM-C11) with sensitivity to simple alkylating agents and a very high level of sister chromatid exchanges. Mutagenesis. 1992;7:265–9. doi:10.1093/mutage/7.4.265.CrossRefPubMed Zdzienicka MZ, van der Schans GP, Natarajan AT, Thompson LH, Neuteboom I, Simons JW. A Chinese hamster ovary cell mutant (EM-C11) with sensitivity to simple alkylating agents and a very high level of sister chromatid exchanges. Mutagenesis. 1992;7:265–9. doi:10.​1093/​mutage/​7.​4.​265.CrossRefPubMed
47.
Zurück zum Zitat Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18:3563–71.CrossRefPubMedPubMedCentral Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18:3563–71.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Abdel-Rahman SZ, El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 2000;159:63–71. doi:10.1016/S0304-3835(00)00532-2.CrossRefPubMed Abdel-Rahman SZ, El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 2000;159:63–71. doi:10.​1016/​S0304-3835(00)00532-2.CrossRefPubMed
55.
Zurück zum Zitat Wu K, Su D, Lin K, Luo J, Au WW. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case–control studies. Asian Pac J Cancer Prev. 2011;12:2237–43.PubMed Wu K, Su D, Lin K, Luo J, Au WW. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case–control studies. Asian Pac J Cancer Prev. 2011;12:2237–43.PubMed
57.
Zurück zum Zitat Pakpong P, Wild O, Akimoto H. Air pollution import to and export from East Asia. Handb Environ Chem. 2004;4G:99–130. doi:10.1007/b94525. Pakpong P, Wild O, Akimoto H. Air pollution import to and export from East Asia. Handb Environ Chem. 2004;4G:99–130. doi:10.​1007/​b94525.
59.
65.
Metadaten
Titel
Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case–control study
verfasst von
Alexandra S. Shadrina
Natalia A. Ermolenko
Uljana A. Boyarskikh
Tatiana V. Sinkina
Alexandr F. Lazarev
Valentina D. Petrova
Maxim L. Filipenko
Publikationsdatum
01.02.2016
Verlag
Springer International Publishing
Erschienen in
Clinical and Experimental Medicine / Ausgabe 1/2016
Print ISSN: 1591-8890
Elektronische ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-014-0329-y

Weitere Artikel der Ausgabe 1/2016

Clinical and Experimental Medicine 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.